Home : Corporate Info : Company News
Company News
Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) Bringing 14 Years of Proven Clinical Trial Capability into the Frontage Suite of Services
Frontage Laboratories, Inc. (http://www.frontagelab.com) (Malvern and Exton, PA USA and Shanghai, P.R. China), a leading high quality provider of bioanalytical, pre-clinical and drug development services to the pharmaceutical industry, announced today it has completed the acquisition of Advanced Biomedical Research, Inc. (ABR) (http://www.abr-pharma.com) (Princeton and Hackensack, NJ USA), an international, full service CRO. Frontage made an
initial 20 percent equity investment in ABR in 2007 and acquires the remaining 80 percent equity with the completion of this transaction. Frontage and ABR now offer unparalleled formulation development, bioanalytical and GMP testing services, Phase I-II study performance in a state-of-the-art 72-bed Clinical Research Center, and international Phase II-IV CRO services.
The combined resources of Frontage and ABR offer offer clients the following benefits:
- Single source for clinical, bioanalytical and drug development services;
- Integrated program management from discovery to commercialization;
- Cost-effective, collaborative R&D services;
- Proven management team;
- Proactive client-centric focus.
“It is Frontage’s goal to be a leading full service provider of quality driven, responsive, client-centric, collaborative R&D services to the pharmaceutical industry. The completion of the acquisition of ABR is a key part of fulfilling that goal,” said Dr. Song Li, Chairman & CEO of Frontage and newly appointed Chairman of ABR. “Over the years, ABR has proven to be a most valuable partner and resource in extending Frontage’s capabilities into the performance and management of clinical trials. With our R&D services expertise in the US and China, and ABR’s turn-key clinical CRO services for conducting and managing Phase I-IV clinical trials, the addition of ABR to the Frontage family allows us to offer a full spectrum of clinical testing and R&D pharmaceutical services to our clients.”
Dr. Michael S. Willett, ABR Founder & President commented, “I am delighted to remain an integral part of ABR and to become a key member of the Frontage management team. By combining Frontage’s R&D services and rapidly expanding presence in the US and China with ABR’s international clinical CRO capabilities and experience in North America and Europe, we are positioned as few others to provide scientifically driven, on-time, cost-effective solutions to our clients through the life cycle of a compound’s development.” Dr. Willett continued, “I’ve repeatedly been impressed with the resourcefulness of our people to work together to solve difficult challenges and to offer proactive solutions to our customers. The learning curve of ABR and Frontage people working together has long since been removed from the equation.”
“We believe the addition of ABR to Frontage provides a solid foundation in clinical trials to build upon and will accelerate the company’s continued expansion in China,” added Mr. Brett Tucker, Partner, Baird Capital Partners Asia, an equity investor in Frontage. “Frontage and ABR’s shared commitment to high quality is readily apparent and their collaborative approach to advancing drug candidates through preclinical and clinical development stages to commercialization brings value to customers.”
For more information, please click on the below link (PDF file):
http://www.abr-pharma.com/downloads/abr-frontage.pdf
About ABR and Frontage (PDF file):
http://www.abr-pharma.com/downloads/aboutabr-frontage.pdf
Recent and Upcoming Meetings Attended by ABR...
2008 Conferences
CPT2008 Québec – The IX th World Conference on Clinical Pharmacology and Therapeutics (July 27 – August 1, 2008) in Québec, Canada. Visit us at Booth #607. http://www.cpt2008.org/
AAPS (American Association of Pharmaceutical Scientists) 2008 Annual Meeting and Exposition (November 16-20, 2008) in Atlanta, Georgia. Visit us at Booth #1343. www.aapspharmaceutica.com
2009 Conferences
ASCPT (American Society for Clinical Pharmacology and Therapeutics) 2009 Annual Meeting (March 18-21, 2009) in Landover, Maryland. Visit us at Booth #235/7. www.ascpt.org
ACRP (Association of Clinical Research Professionals) 2009 Global Conference & Exhibition (April 24-28, 2009) in Denver, Colorado. Visit us at Booth #509/11. www.acrpnet.org
Partnerships with CROs (April 28-30, 2009) in Orlando, Florida. Visit us at Booth #546. www.iirusa.com
DIA (Drug Information Association) 2009 Annual Meeting (June 21-25, 2009) in San Diego, California. www.diahome.org
AAPS (American Association of Pharmaceutical Scientists) 2009 Annual Meeting and Exposition (November 8-12, 2009) in Los Angeles, California. www.aapspharmaceutica.com